Protocol Ledger

NCT04924868 · Phase III · RECRUITING

Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis

Interventional Phase III clinical trial protocol NCT04924868 sponsored by Hospital General Universitario de Alicante in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-11-10 Enrollment: 332 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04924868
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)332 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04924868
Protocol FieldVerified Registry Value
NCT IdentifierNCT04924868
Consolidated Lead SponsorHospital General Universitario de Alicante
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment332 participants (ESTIMATED)
Registered Start Date2021-11-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI